Intestinal inflammatory pharmaceutics Curator: Larry H. Bernstein, MD, FCAP AbbVie Invests in Synthetic Microbes for Treatment of Intestinal Disorders Aaron Krol    http://www.bio-itworld.com/2016/2/10/abbvie-invests-synthetic-microbes-treatment-intestinal-disorders.html Intestinal Inflammatory Pharmaceutics, Volume 2 (Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology), Part 2: CRISPR for Gene Editing and DNA Repair … Continue reading Intestinal inflammatory pharmaceutics